CASP3 and hepatocellular carcinoma: Overexpression of Ets-1 in naive HCC cells, reduced apoptosis, mitochondrial damage, and caspase 3/7 activation upon stimulation with sorafenib (Fig. 5), indicative of sorafenib resistance.